跳至主要内容
临床试验/TCTR20230331002
TCTR20230331002招募中1 期

Smart phone application with internet of things for early detection of adverse clinical outcomes in solid malignancy

Invitrace Company Limited0 个研究点目标入组 30 人开始时间: 2023年3月31日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 60 Years(—)
性别
All

入选标准

  • 1.Thai patients aged 18-60 years
  • 2.Received a Cancer Diagnosis From the results of pathological confirmation or diagnostic imaging results
  • 3.Patients whose stages can be identified from early stages to metastatic stages (divided according to TNM staging)
  • 4.Patients must be receiving chemotherapy or chemotherapy in combination with other treatments such as targeted drugs, including radiotherapy. And must receive treatment within 3 months from the start of treatment until the date of study participation.
  • 5.Patients must be in good physical condition as assessed using the Eastern Cooperative Oncology Group (ECOG) performance status (must be in the range of 0-2).
  • 6.Able to read Thai and use a mobile phone, which means a phone that adds various capabilities to increase user convenience. It is like a mobile computer for the user. This is not limited to whether it is just a phone that can only make calls or just see the time or has someone to give advice on using the application. and/or a mobile phone that operates like a computer at all times

排除标准

  • 1.Patients with end-of-life chronic disease who have an end-of-life care plan
  • 2.Patients already participating in other studies

研究者

发起方
Invitrace Company Limited

相似试验